Cannabinoids
US7285687B2 · kind B2 · utility
0Cited by
9References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 20, 2002 |
| Grant date | Oct 23, 2007 |
| Priority date | — |
| Expiry date | Jun 20, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D335/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula: wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.